Management of asymptomatic hyperparathyroidism.

Area of Science:

• Endocrinology
• Surgical Oncology

Background:

• Asymptomatic hyperparathyroidism is increasingly diagnosed, necessitating evaluation of surgical outcomes.
• Historical data shows a significant increase in surgical interventions for this condition over time.

Purpose of the Study:

• To evaluate the efficacy and safety of surgical therapy for uncomplicated biochemical or asymptomatic hyperparathyroidism.
• To analyze factors influencing surgical outcomes, including gland identification and patient selection.

Main Methods:

• Retrospective analysis of 242 patients undergoing surgery for asymptomatic hyperparathyroidism between 1971 and 1982.
• Review of surgical procedures, including unilateral and bilateral cervical explorations and reexplorations.
• Correlation of gland size and pathology with preoperative serum calcium levels.

Main Results:

• Surgery resulted in normocalcemia in 98.3% of patients with no deaths or recurrent nerve injuries.
• Predominant pathologies were adenomas (83.1%) and hyperplasias (16.1%).
• Larger abnormal glands correlated with higher serum calcium levels, aiding in identification.

Conclusions:

• Surgical intervention is a safe and highly effective treatment for asymptomatic hyperparathyroidism.
• Patients with serum calcium >11 mg/100 ml or evidence of end-organ damage warrant prompt surgical consideration.
• Expectant management may be suitable for milder cases, but long-term risks necessitate careful monitoring and potential delayed surgical intervention.